Purification of sugammadex

Phosphonamide ester compound, salt thereof, related crystal form thereof, preparation method therefor and use thereof

Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

Modulators of alpha-1 antitrypsin

SOLID STATE FORMS OF BRANAPLAM AND THEIR PREPARATION

CRYSTAL FORM OF ABEMACICLIB MESYLATE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION THEREOF

Compositions and methods for delivering pharmaceutical agents

ACID ADDITION SALTS OF APOMORPHINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME

Crystalline form of EB-1020, processes for preparation and use thereof

Co-crystal of sorafenib derivatives and process for preparation thereof

Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient

Platform drug delivery system utilizing crystal engineering and theanine dissolution

CRYSTALLINE FORMS OF SELECTIVE PROGESTERONE RECEPTOR MODULATOR, PROCESSES FOR PREPARATION THEREOF

D-allose crystal and production method thereof

Pyridine and pyrimidine derivatives

COMPOUND OF EOC315 MOD.I CRYSTAL FORM AND PREPARATION METHOD THEREOF

Purinone compounds and their use in treating cancer

Process for Manufacturing Pibrentasvir Active Drug Substance

Solid forms of a plasma kallikrein inhibitor and salts thereof

Crystalline and salt forms of PPAR agonist compounds

Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

AMORPHOUS FORM OF PIMAVANSERIN HEMITARTRATE

Crystalline form of sofpironium bromide and preparation method thereof

Diamond pressure apparatus for crystallizing cannabinoids

Gremlin-1 crystal structure and inhibitory antibody

Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate

Salts and polymorphs of cethromycin for the treatment of disease

Borate of azetidine derivative

SOLID STATE FORMS OF LORLATINIB AND THEIR PREPARATION

Ion channel modulators

Process for preparing modulators of p300 and/or CBP

CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF

GLP-1 Receptor Agonists and Uses Thereof

Crystalline forms of lenalidomide

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Crystal of benzoxazole derivative

Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof

Salts of a Pim kinase inhibitor

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

Method for preparing novel crystalline forms of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea

Polymorphs of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea

Crystalline tranilast salts and their pharmaceutical use

SOLID FORMS AND FORMULATIONS COMPRISING A GLUCOCORTICOID RECEPTOR ANTAGONIST AND USES THEREOF

Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof

IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

Crystal form of Baricitinib and preparation method thereof

Processes for preparing an FGFR inhibitor

ISOTHERMAL REACTIVE CRYSTALLISATION PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM OF PIMODIVIR HYDROCHLORIDE HEMIHYDRATE

Compounds and methods of preparing compounds S1P1 modulators

Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine

Polymorph of HDAC6-selective inhibitor and application thereof

Densely charged catenanes

Oxazole compound crystal

CRYSTALLINE FORMS OF A MAGL INHIBITOR

Solid state crystalline forms of a selective potassium channel modulator

Method for extracting and isolating lutein crystal from vegetable oil resin containing lutein diester

Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same

Crystal form and amorphous form of dezocine analogue hydrochloride

Zuclomiphene salts and crystalline forms thereof

Fenfluramine compositions and methods of preparing the same

Process for the preparation of iloprost

Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts

CRYSTALLINE FORMS OF OBETICHOLIC ACID

NOVEL POLYMORPHIC FORM OF FERRIC MALTOL

Salts and crystalline forms of a PD-1/PD-L1 inhibitor

Solid forms of an S1P-receptor modulator

Crystal forms of thiophene derivatives

Methods of treating painful diabetic peripheral neuropathy

Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

Tartrate of selective CDK9 inhibitor and crystal form thereof

Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same

Methods and processes for the preparation of KDM1A inhibitors

Crystal form of 3-(4-methyl-1h-imidazol-1-yl)-5-trifluoromethylaniline monohydrochloride and use thereof

Crystalline form of lenvatinib mesylate and methods thereof

Salt forms of a complement component C5A receptor

Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt

Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof

2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making the same

Production method for 1-amino cyclopropane carboxylic acid nonhydrate

Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME

Methods of making bempedoic acid and compositions of the same

Free base crystalline form of a complement component C5a receptor

Crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate

CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF

MEDICAL USE OF COMPOUND III

Crystalline forms of Acalabrutinib

Solid state forms of Venetoclax and its process for the preparation there of

OPIOID RECEPTOR (MOR) AGONIST SALT, FUMARATE SALT CRYSTAL FORM I THEREOF AND PREPARATION METHOD THEREOF

Solid forms of Cerdulatinib

Salt forms of amino pyrazine purine based selective kinase inhibitor

Long-acting injectable formulations and crystalline forms of buprenorphine derivatives

Process for the preparation of ribociclib succinate and its novel crystalline forms thereof

Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

Salts and solid state forms of plinabulin

Polymorph of flibanserin and preparation method thereof and use of same

Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride

Forms of fedratinib dihydrochloride

Process for synthesis of a phenoxy diaminopyrimidine compound

Crystal forms of oxypyridine amide derivative and preparation method therefor

Trisodium sacubitril valsartan and process for its preparation

Glucagon receptor antagonists

Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators

Cocrystal

Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide

Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof

Solid forms comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same

A2-73 crystalline polymorph compositions of matter and methods of use thereof

Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

Crystalline substituted pyrazines as PGI2 receptor agonists

Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol

Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide

Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

Hydrochloride salt of 2-((3R,4S)-1-(5-(4-chloro-3,5-difluorophenyl)-7-((2-fluoro-6-methylphenyl)(methyl)amino)pyrazolo[1,5-a]pyrimidine-2-carbonyl)-3-methoxypiperidin-4-yl) acetic acid and crystals thereof

[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases

Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid

Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl- D3)pyridazine-3-carboxamide

Compounds, compositions and methods

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof

Method for purifying crystals using solvent vapors

Co-crystals of lithium benzoate and uses thereof

Methods and compositions for treating retina-associated disease using CCR3-inhibitors

Crystalline solid forms of a BET inhibitor

6-pyrimidin-isoindole derivative as ERK1/2 inhibitor

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

Pharmaceutical co-crystal composition and use thereof

DIARYL MACROCYCLE POLYMORPH

Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production

Solid state forms of rucaparib and of rucaparib salts

Form of ponatinib

Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

SALT AND CRYSTAL OF TRIAZOLOPYRAZINE DERIVATIVE

Crystalline forms of nicotinamide riboside chloride

COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM

Process for the preparation of (S)-Netarsudil,its salts and polymorphs

Crystalline particles of bis-choline tetrathiomolybdate

Crystalline forms of deltamethrin and methods of use thereof

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Salt serving as AKT inhibitor and crystal thereof

BCKDK inhibitors

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator

Triazolopyrimidine compounds and their use in treating cancer

NEW CRYSTAL FORM OF ACALBRUTINIB, PREPARATION METHOD THEREFOR AND USE THEREOF

Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates Thereof

Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Crystalline Form II of Darolutamide

PROCESS OF MAKING SOMATOSTATIN MODULATORS

PHARMACEUTICALLY ACCEPTABLE SALTS OF BENZODICYCLOALKANE DERIVATIVE, POLYMORPHIC SUBSTANCE THEREOF, AND APPLICATION THEREOF

AN IMPROVED PROCESS FOR THE PREPARATION OF VORTIOXETINE AND SALTS THEREOF

Tebuconazole polymorph and preparation method therefor

Crystalline polymorphs of Pracinostat and Pracinostat salts

Crystalline siponimod fumaric acid and polymorphs thereof

SHP2 phosphatase inhibitors and methods of making and using the same

Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor

Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof

Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole

Purification of cannabinoids from crude cannabis oil

Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor

Type-B fenolamine crystal form, preparation method, composition and use thereof

Polymorphic compounds and uses thereof

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Method for the production of lumateperone and its salts

Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and purification method and application thereof

Cyclopentane compounds

METHOD FOR PRODUCING 2-ACETYL-4H,9H-NAPHTHO[2,3-B]FURAN-4,9-DIONE

CRYSTAL FORM OF SESQUITERPENE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

Method for purifying and removing color of FDCA

Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors

Crystalline bis- and tris-hydrochloride salt of elamipretide

IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation

Process and crystalline forms of Lumacaftor

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Method for preparing tolimidone on large scale

Crystal forms and production methods thereof

Polymorphic forms of deoxycytidine, compositions comprising the same and uses

4-substituted benzoxaborole compounds and uses thereof

Salts, crystal forms, and production methods thereof

Inhibitors of the menin-MLL interaction

Crystal form of monomethanesulfonate of deuterated 3-(4,5-substituted aminopyrimidine)phenyl compound and preparation method therefor

Crystalline forms of Actinomycin D for treatment of cancer

Processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Salt Forms Of 4-Cyano-N-(4,4-Dimethylcyclohex-1-EN-1-YL)-6-(2,2,6,6-Tetramethyltetrahydro-2H-Pyran-4-YL)Pyridin-3-YL)-1H-Imidazole-2-Carboximide

Process and crystalline forms of lumacaftor

Acryloyl-containing nuclear transport regulators and uses thereof

Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof

POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Process for the preparation of polymorph form B of treprostinil diethanolamine salt

Aqueous Leaching Method to Produce Microcrystalline Powder

Crystalline salt forms

Crystal forms of an antitumor agent and their preparation methods

Method for preparation of Asenapine

Crystalline forms of CFTR modulators

Process for preparation of Deutetrabenazine

Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

Crystal form targeting CDKkinase inhibitor

Fasoracetam crystalline forms

Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof

LOW DOSE COMPOSITIONS OF ARAMCHOL SALTS

CRYSTALLINE FORMS OF QUINOLINE ANALOGS AND SALTS THEREOF, COMPOSITIONS, AND THEIR METHODS FOR USE

ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE

Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof

Crystalline form of oxamyl process for its preparation and use of the same

Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst

New Polymorphs of Dolutegravir Sodium

Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b] [1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with phosphoric acid as GABAA positive allosteric modulators

Salts of a PD-1/PD-L1 inhibitor

Solid forms of an HPK1 inhibitor

EGFR inhibitors

Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses

Salt of delmopinol

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

Method for preparing mesaconine and related intermediaries thereof

Process for the preparation of a PDE4 inhibitor

Process for the preparation of metformin

Constant shear continuous reactor device

Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application

CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR

(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL-5-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-YL)AMINO)PIPERIDINE-1-CARBOXYLATE FOR INHIBITING CDK7

Compounds useful as inhibitors of ATR kinase

Crystalline forms of dasatinib

Crystalline salts of peptide epoxyketone immunoproteasome inhibitor

Process for the preparation of lifitegrast

Crystal form of small molecule immune compound, preparation method thereof and pharmaceutical composition containing the same

Succinate forms and compositions of Bruton's tyrosine kinase inhibitors

Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone

Resveratrol-piperazine co-crystals

Certain chemical entities, compositions, and methods

Salt forms of URAT-1 inhibitors

Crystalline forms and methods of producing crystalline forms of a compound

Salt of pentacyclic compound and crystal thereof

Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof

Processes for preparing ACC inhibitors and solid forms thereof

BCKDK inhibitors

Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Solid form of dihydropyrimidine compound and preparation method therefor and use thereof

Polymorphic forms of Afatinib free base and Afatinib dimaleate

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of use thereof

Crystal modifications of odevixibat

(S)-CSA Salt Of S-Ketamine, (R)-CSA Salt Of S-Ketamine And Processes For The Preparation Of S-Ketamine

Crystal of compound having JAK-inhibiting activity

Solid state forms of Relugolix

Morphic forms of marizomib and uses thereof

Pyridine or N,N-dimethyl acetamide solvated solid state forms of solvated idelalisib, their use and preparation

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

Crystalline forms of niraparib tosylate

Crystalline forms of ARN-509, preparation method and use thereof

Salts of an epidermal growth factor receptor kinase inhibitor

Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents

Solid-state forms of Abemaciclib, their use and preparation

Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Solid-state forms of Regadenoson, their use and preparation

PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY

Method for producing allulose crystals

Crystalline forms

Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof

Purinone derivative hydrochloride

ERBB receptor inhibitors

CRYSTALLINE FORMS OF MODULATORS OF CFTR

Method for producing the crystalline form of modification a of calcobutrol

Crystalline forms of plasma kallikrein inhibitors

Menaquinol compositions and methods of treatment

Crystal forms of crisaborole in free form and preparation method and use thereof

Crystal form of ethyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate hydrochloride

SOLID FORMS OF IBRUTINIB

PROCESS FOR PREPARATION OF PALBOCICLIB

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and purification method and application thereof

Crystal of a caspase inhibitor

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

NOVEL CRYSTALLINE FORMS OF TAMIBAROTENE FOR TREATMENT OF CANCER

PROCESS FOR THE PREPARATION OF ABAMETAPIR AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

Method for producing functional crystalline sweetener

POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1-(ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

Process for the preparation of Crisaborole in a stable crystal form

Solid forms of stemospironine and its salts

CRYSTALLINE FORMS OF VENETOCLAX

Crystal form and salt form of pyridoimidazole compound and preparation method therefor

Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof

Method for preparing natural L-cysteine hydrochloride hydrate crystals by continuous chromatography

Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production

Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof

Benzisoxazole sulfonamide derivatives

Polymorphs and new path to synthesize Tafamidis

Solid forms comprising an oxime ether compound, compositions and methods of use thereof

2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors